6,6'-bieckol profile

6,6'-bieckol: structure given in first source; antiplasmin antag [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

6,6'-bieckol : A phlorotanin that is 1,1'-bioxanthrene substituted by 3,5-dihydroxyphenoxy groups at position 6 and 6' and hydroxy groups at positions 2, 2', 4, 4', 7, 7', 9 and 9' respectively. It is isolated from an edible marine brown alga Ecklonia cava and exhibits antioxidant activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

ID Source	ID
PubMed CID	137388
CHEMBL ID	502202
CHEBI ID	65496
SCHEMBL ID	1353030
MeSH ID	M0172656

Synonym
(1,1'-bidibenzo(b,e)(1,4)dioxin)-2,2',4,4',7,7',9,9'-octol, 6,6'-bis(3,5-dihydroxyphenoxy)-
unii-87u82w6ifi
88095-81-2
87u82w6ifi ,
6,6'-bieckol
4-(3,5-dihydroxyphenoxy)-9-[6-(3,5-dihydroxyphenoxy)-2,4,7,9-tetrahydroxy-dibenzo-p-dioxin-1-yl]dibenzo-p-dioxin-1,3,6,8-tetrol
CHEMBL502202 ,
chebi:65496 ,
6,6'-bis(3,5-dihydroxyphenoxy)-(1,1'-bidibenzo[b,e][1,4]dioxin)-2,2',4,4',7,7',9,9'-octol
6,6'-bis(3,5-dihydroxyphenoxy)-1,1'-bioxanthrene-2,2',4,4',7,7',9,9'-octol
4-(3,5-dihydroxyphenoxy)-9-[6-(3,5-dihydroxyphenoxy)-2,4,7,9-tetrahydroxyoxanthren-1-yl]oxanthrene-1,3,6,8-tetrol
SCHEMBL1353030
DTXSID50236812
bdbm50479418
6,6''''-bieckol
Q4641520
6,6-bieckol

Role	Description
metabolite	Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
radical scavenger	A role played by a substance that can react readily with, and thereby eliminate, radicals.
anti-HIV-1 agent	An anti-HIV agent that destroys or inhibits the replication of HIV-1, the more infective and more virulent of the two types of HIV virus.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
phlorotannin	A type of tannin usually found in brown algae such as kelps and rockweeds. Unlike the hydrolysable or condensed tannins, these compounds are oligomers of phloroglucinol.
aromatic ether	Any ether in which the oxygen is attached to at least one aryl substituent.
oxacycle	Any organic heterocyclic compound containing at least one ring oxygen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Reverse transcriptase/RNaseH	Human immunodeficiency virus 1	EC50 (µMol)	1.0700	0.0004	0.6153	9.7000	AID363916
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (37)

Assay ID	Title	Year	Journal	Article
AID364086	Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p24 antigen production at 10 uM by ELISA	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363928	Inhibition of HIV1 3B recombinant protease	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393272	Antioxidant activity assessed as superoxide radical scavenging activity	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID363916	Inhibition of HIV1 3B reverse transcriptase activity	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393270	Antioxidant activity assessed as Fenton system generated hydroxyl radical scavenging activity by ESR spectrometer	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID363929	Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p55 gag protein production after 4 days by Western blot analysis	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363926	Antiviral activity against HIV1 3B in human C8166 co-cultivated with H9 cells assessed as inhibition of cell-virus fusion after 72 hrs	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393285	Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells at 10 uM by spectrophotometrically	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID363918	Antiviral activity against HIV1 3B in human C8166 cells assessed as inhibition of viral-induced syncytia formation after 72 hrs	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363924	Inhibition of HIV1 3B reverse transcriptase activity at 10 uM	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363923	Inhibition of HIV1 3B reverse transcriptase activity at 1 uM	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393281	Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production at 50 uM after 210 mins measured by fluorescent dichlorofluorescein using DCFH-DA substrate	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393276	Cytotoxicity against human HL60 cells at 100 uM after 24 hrs by MTT assay	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID364083	Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p24 gag protein production after 4 days by Western blot analysis	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363925	Antiviral activity against HIV1 3B in human C8166 co-cultivated with H9 cells assessed as inhibition of cell-cell fusion after 72 hrs	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID364085	Cytotoxicity against human CEM-SS cells up to 500 by MTT assay	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393273	Antioxidant activity assessed as APPH generated peroxyl radical scavenging formation by ESR spectrometer	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID363930	Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p41 gag protein production after 4 days by Western blot analysis	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363922	Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p24 antigen production by ELISA	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363919	Antiviral activity against HIV1 3B in human C8166 cells assessed as inhibition of viral-induced syncytia formation at 25 uM after 72 hrs	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393277	Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production measured by fluorescent dichlorofluorescein using DCFH-DA substrate	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393284	Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells by spectrophotometrically	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID364084	Therapeutic index, ratio of CC50 for human CEM-SS cells to IC50 for HIV1 induced lytic effect	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393283	Increase in intracellular GSH level in mouse RAW264.7 cells assessed as monobromobimane-GSH fluorescence intensity at 20 uM after 120 mins	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393274	Cytotoxicity against human MRC5 cells at 100 uM after 24 hrs by MTT assay	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID364087	Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of p24 antigen production at 25 uM by ELISA	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363917	Cytotoxicity against human CEM-SS cells after 72 hrs by MTT assay	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393278	Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production after 200 mins measured by fluorescent dichlorofluorescein using DCFH-DA substrate	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID363927	Antiviral activity against HIV13B in human C8166 co-cultivated with H9 cells assessed as inhibition of viral-induced syncytia formation at 25 uM after 72 hrs	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID363920	Antiviral activity against HIV1 3B in human CEM-SS cells assessed as inhibition of viral-induced lytic effect after 7 days by MTT assay	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393282	Inhibition of Fe(2+)/H2O2-generated hydroxyl radical induced membrane protein oxidation in mouse RAW264.7 cells at 1 uM to 50 uM relative to control	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID363921	Antiviral activity against HIV1 3B in human CEM-SS cells assessed as inhibition of viral-induced lytic effect at 25 uM after 7 days by MTT assay	2008	Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17	Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.
AID393279	Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production at 1 uM after 200 mins measured by fluorescent dichlorofluorescein using DCFH-DA substrate	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393271	Antioxidant activity assessed as DPPH radical scavenging activity	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393280	Antioxidant activity against mouse RAW264.7 cells assessed as reduction of ROS production at 50 uM after 200 mins measured by fluorescent dichlorofluorescein using DCFH-DA substrate	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393286	Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells at 50 uM by spectrophotometrically	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
AID393275	Cytotoxicity against mouse RAW264.7 cells at 100 uM after 24 hrs by MTT assay	2009	Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5	Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (5.88)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (23.53)	29.6817
2010's	11 (64.71)	24.3611
2020's	1 (5.88)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	17 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
phloroglucinol Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.. phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.	3.5	7	benzenetriol; phenolic donor	algal metabolite
pyrogallol benzenetriol : A triol in which three hydroxy groups are substituted onto a benzene ring.	3.11	4	benzenetriol; phenolic donor	plant metabolite
zidovudine Zidovudine: A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.. zidovudine : A pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase.	2.96	1	azide; pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
phlorofucofuroeckol a phlorofucofuroeckol A: phlorotannin from Ecklonia kurome; structure given in first source	2.48	2
eckol eckol: structure given in first source; isolated from brown alga Ecklonia kurome Okamura; inhibitor of alpha 2-antiplasmin. eckol : A phlorotannin that is oxanthrene-1,3,6,8-tetrol substituted by a 3,5-dihydroxyphenoxy moiety at position 4. Isolated from the marine brown alga, Ecklonia cava, it exhibits antioxidant activity.	2.44	2	phlorotannin	antioxidant; metabolite
benzofurans Benzofurans: Compounds that contain a BENZENE ring fused to a furan ring.	2.77	3
8,8'-bieckol 8,8'-bieckol: structure given in first source; antiplasmin antagonist	3.32	2
dieckol dieckol: found in brown Eisenia and Ecklonia algae, have several pharmacologically beneficial effects such as anti-inflammation; structure in first source. dieckol : A phlorotannin isolated from a brown alga Ecklonia cava which exhibits antioxidant, hepatoprotective and anticoagulant activities.	2.98	4	aromatic ether; oxacycle; phlorotannin	anticoagulant; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; metabolite; radical scavenger
dinoprostone prostaglandin E2 : Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.	2.45	2	prostaglandins E	human metabolite; mouse metabolite; oxytocic
7-phloroeckol 7-phloroeckol: isolated from Ecklonia cava; structure in first source. 7-phloroeckol : A phlorotannin that is eckol in which the hydroxy group at position 7 is replaced by a 2,4,6-trihydroxyphenoxy group. Isolated from the marine brown alga, Ecklonia cava, it exhibits antioxidant activity.	2.05	1	aromatic ether; phlorotannin	antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite
diphlorethohydroxycarmalol diphlorethohydroxycarmalol: carmalol derivative from a brown Alga, Ishige okamurae with inhibitory activity on HIV-1 reverse transcriptase and integrase; structure in first source	2.04	1
tannins Tannins: Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS). The two main types are HYDROLYZABLE TANNINS and CONDENSED TANNINS. Historically, the term has applied to many compounds and plant extracts able to render skin COLLAGEN impervious to degradation. The word tannin derives from the Celtic word for OAK TREE which was used for leather processing.	3.03	4

Condition	Relationship Strength	Studies
Skin Aging The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.	2.41	1
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	2.21	1
Innate Inflammatory Response [description not available]	2.83	3
Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).	2.21	1
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	7.83	3
Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).	7.61	2
Diseases, Peripheral Vascular [description not available]	2.21	1
Peripheral Vascular Diseases Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.	2.21	1
Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.	2.17	1
Blood Pressure, High [description not available]	2.21	1
Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.	2.21	1
Breast Cancer [description not available]	2.11	1
Breast Neoplasms Tumors or cancer of the human BREAST.	2.11	1
Adenoma, beta-Cell [description not available]	2.11	1
Cancer of Pancreas [description not available]	2.11	1
Insulinoma A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.	7.11	1
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).	2.11	1
Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)	7.05	1
Anasarca [description not available]	2.07	1
Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.	2.07	1
Cancer, Radiation-Induced [description not available]	2.03	1
Cancer of Skin [description not available]	2.03	1
Skin Neoplasms Tumors or cancer of the SKIN.	2.03	1

6,6'-bieckol

Description

Cross-References

Synonyms (17)

Roles (3)

Drug Classes (3)

Protein Targets (1)

Activation Measurements

Bioassays (37)

Research

Studies (17)

Market Indicators

Research Demand Index: 11.73

Study Types

6,6'-bieckol

Description

Cross-References

Synonyms (17)

Roles (3)

Drug Classes (3)

Protein Targets (1)

Activation Measurements

Bioassays (37)

Research

Studies (17)

Market Indicators

Research Demand Index: 11.73

Study Types

Related Drugs (12)

Related Conditions (23)